What it's for (Indications)
- Aceclofenac is primarily indicated for the symptomatic treatment of pain and inflammation associated with a range of musculoskeletal and joint disorders.
- These include, but are not limited to, osteoarthritis, a degenerative joint disease characterized by cartilage breakdown; rheumatoid arthritis, a chronic autoimmune inflammatory disorder primarily affecting joints; and ankylosing spondylitis, a chronic inflammatory disease primarily affecting the spine and large joints.
- It is also utilized for other painful conditions such as periarthritis of shoulder-scapulum, sciatica, lumbago, cervicobrachialgia, and acute musculoskeletal sprains and strains.
- The therapeutic aim is to reduce pain and inflammation, thereby improving mobility and quality of life for patients suffering from these debilitating conditions.
- Its use should be carefully considered based on the patient's overall health profile and specific disease characteristics, always striving for the lowest effective dose for the shortest duration necessary.
Dosage Information
| Type | Guideline |
|---|---|
| Standard | The standard adult dosage of aceclofenac is typically 100 mg, administered orally twice daily, ideally one tablet in the morning and one in the evening. It is generally recommended to take the medication with or after food to minimize potential gastrointestinal irritation. The maximum recommended daily dose should not exceed 200 mg. Dosage adjustments may be necessary in specific patient populations, such as the elderly, who may be more susceptible to adverse effects, and individuals with mild to moderate renal or hepatic impairment. In such cases, a reduced initial dose and careful monitoring are advised. Aceclofenac is not recommended for use in children. The duration of treatment should be as short as possible and at the lowest effective dose to mitigate the risk of adverse reactions, consistent with the patient's clinical response and tolerability and periodic reassessment of the need for continued therapy. |
Safety & Warnings
Common Side Effects
- Aceclofenac, like other NSAIDs, can cause a range of side effects, some of which can be serious.
- Common gastrointestinal side effects include dyspepsia, abdominal pain, nausea, diarrhea, and flatulence.
- More severe GI effects, such as gastrointestinal ulceration, perforation, or bleeding, can occur, sometimes without warning symptoms, and may be fatal.
- Central nervous system effects can include dizziness, headache, and rarely, paresthesia or tremor.
- Dermatological reactions, including rash and pruritus, are also possible, with rare but serious skin reactions like Stevens-Johnson syndrome or toxic epidermal necrolysis.
- Hepatic adverse events, such as elevated liver enzymes (transaminases), have been reported, with rare instances of severe liver injury including hepatitis.
- Renal side effects include fluid retention, edema, and hypertension, and in predisposed individuals, acute renal failure, interstitial nephritis, or nephrotic syndrome.
- Cardiovascular risks, including an increased risk of serious cardiovascular thrombotic events (myocardial infarction and stroke), are also a significant concern, particularly with prolonged use or high doses.
- Other less common side effects include visual disturbances, anemia, and palpitations.
Serious Warnings
- Black Box Warning: **WARNING: CARDIOVASCULAR THROMBOTIC EVENTS AND GASTROINTESTINAL RISK** **CARDIOVASCULAR THROMBOTIC EVENTS:** Non-steroidal anti-inflammatory drugs (NSAIDs), including aceclofenac, increase the risk of serious cardiovascular thrombotic events, including myocardial infarction (MI) and stroke, which can be fatal. This risk may occur early in treatment and may increase with duration of use and higher dosages. Patients with known cardiovascular disease or risk factors for cardiovascular disease may be at greater risk. Aceclofenac is contraindicated in the setting of coronary artery bypass graft (CABG) surgery due to the increased risk of myocardial infarction and stroke. Prescribers should use the lowest effective dose for the shortest duration possible consistent with individual patient treatment goals to minimize potential risks. **GASTROINTESTINAL RISK:** NSAIDs, including aceclofenac, increase the risk of serious gastrointestinal (GI) adverse events including bleeding, ulceration, and perforation of the stomach or intestines, which can be fatal. These events can occur at any time during use and without warning symptoms. Elderly patients and patients with a prior history of peptic ulcer disease and/or GI bleeding are at greater risk for serious GI events. Concomitant use of aspirin, corticosteroids, selective serotonin reuptake inhibitors (SSRIs), or other NSAIDs further increases this risk. Appropriate gastroprotective measures should be considered for at-risk patients, but these do not completely eliminate the risk. Therapy should be discontinued immediately if gastrointestinal bleeding or ulceration is suspected.
- Patients with a history of gastrointestinal ulceration or bleeding, or those concurrently taking anticoagulants, aspirin, or corticosteroids, are at significantly increased risk of developing serious gastrointestinal complications; aceclofenac should be used with extreme caution in these individuals, and often, gastroprotective agents are recommended.
- Cardiovascular risks include the potential for new onset of hypertension or worsening of pre-existing hypertension, fluid retention, and edema, necessitating careful monitoring of blood pressure.
- NSAIDs can cause dose-dependent renal toxicity, and aceclofenac should be used cautiously in patients with impaired renal function, heart failure, liver dysfunction, and in the elderly, where monitoring of renal function is crucial.
- Hepatic function should be monitored periodically during long-term therapy.
- Patients with asthma, allergic rhinitis, chronic obstructive pulmonary disease, or chronic infections of the respiratory tract are more likely to react with asthmatic attacks, urticaria, or angioedema.
- Aceclofenac may mask the signs of infection.
- Use in late pregnancy (third trimester) should be avoided due to the risk of premature closure of the fetal ductus arteriosus.
- Patients should be advised to report any adverse reactions promptly, especially signs of gastrointestinal bleeding or cardiovascular events.
How it Works (Mechanism of Action)
Aceclofenac exerts its anti-inflammatory, analgesic, and antipyretic effects primarily through the inhibition of prostaglandin synthesis. It achieves this by inhibiting the cyclooxygenase (COX) enzymes, particularly COX-2, which is induced at sites of inflammation and responsible for the production of pro-inflammatory prostaglandins that mediate pain, inflammation, and fever. While aceclofenac exhibits some selectivity towards COX-2 in vitro, it also inhibits COX-1 to a certain extent, especially at higher concentrations. Inhibition of COX-1 is associated with many of the gastrointestinal side effects of NSAIDs, as COX-1 produces prostaglandins important for gastric mucosal protection and platelet aggregation. By reducing the synthesis of prostaglandins, aceclofenac decreases inflammation, pain, and fever. Additionally, some studies suggest that aceclofenac may also possess other mechanisms, including modulation of cytokine production (e.g., IL-1β, TNF-α) and inhibition of nitric oxide synthesis, contributing to its overall therapeutic efficacy in inflammatory conditions. Its ability to concentrate in synovial fluid may also contribute to its efficacy in joint disorders.